Eximo Medical is a startup that operates in the medical technology sector, specifically focusing on peripheral atherectomy technology. This technology is used to treat peripheral arterial disease (PAD), a condition where plaque builds up in the arteries that supply blood to the limbs, typically the legs. Eximo's technology, the Auryon System, is designed to clear all types of lesions, including in-stent restenosis (ISR), which is a re-narrowing of an artery after a stent has been placed to treat a previous blockage.

Eximo's business model revolves around the sale of its Auryon System to healthcare providers, such as hospitals and clinics. The company's technology is backed by clinical trials, which have shown reductions in plaque burden and high patency rates, meaning the treated arteries remain open and unblocked. This technology is designed to be used both above and below the knee, offering a comprehensive solution for PAD treatment.

Eximo's Auryon System is unique in its ability to minimize the risk of embolization, a potentially serious complication where a piece of the plaque breaks off and travels to the heart or brain. This feature adds a layer of safety and confidence for healthcare providers using the technology.

In summary, Eximo Medical is a promising startup in the medical technology sector, offering a unique and effective solution for the treatment of peripheral arterial disease.

Keywords: Medical Technology, Peripheral Atherectomy, Peripheral Arterial Disease, In-Stent Restenosis, Auryon System, Plaque Reduction, Patency Rates, Above and Below Knee Treatment, Minimized Embolization Risk, Healthcare Providers.